{"id":"W1925087877","doi":"10.1111/j.1468-3083.2011.04332.x","title":"Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Welichem Biotech (Canada); Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Randomized controlled trial; Adverse effect; Psoriasis Area and Severity Index; Body surface area; Clinical endpoint; Internal medicine; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002281323,0.00124828,0.003083588,0.0003498908,0.0004249355,0.0009470017,0.0007946205,0.001770971,0.006099415],"category_scores_gemma":[0.001935473,0.0005763873,0.001388938,0.0004204097,0.0009768272,0.0007005933,0.0002549245,0.002208271,0.0009240003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004257178,"about_ca_system_score_gemma":0.0008803445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003926507,"about_ca_topic_score_gemma":0.0009122764,"domain_scores_codex":[0.9992892,0.0003968607,0.00005429942,0.0001073326,0.00007575238,0.00007658615],"domain_scores_gemma":[0.9988556,0.0003842621,0.0003062242,0.00007311603,0.0000716887,0.0003090666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9504148,0.008845711,0.0008323985,0.001511007,0.001120331,0.00004738372,0.00005535446,0.0001856824,0.00699802,0.00007236982,0.0009960863,0.02892097],"study_design_scores_gemma":[0.9545558,0.04247698,0.001807277,0.00004554293,0.0002816777,0.00003413276,0.000009156033,0.0001236607,0.0002482388,0.00004829238,0.0003604395,0.00000876814],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.971768,0.01716873,0.001104891,0.001043957,0.0005236575,0.004681741,0.001084673,0.0001990055,0.002425386],"genre_scores_gemma":[0.9753338,0.0094951,0.002137338,0.002019776,0.0006261324,0.006408664,0.00124308,0.00003904679,0.002697054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006099415,"threshold_uncertainty_score":0.02040452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03312076175434684,"score_gpt":0.264419496675059,"score_spread":0.2312987349207122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}